Formerly known as Knoll Pharmaceuticals Limited, Abbott India Limited (AIL) is a subsidiary of Abbott Capital India Limited in which the latter holds about 69% stake. It is involved in the discovery, development, manufacture and marketing of pharmaceutical, diagnostic, nutritional and hospital products in India. AIL offers products in the areas of pain management and gastroenterology primarily under the 'Brufen', 'Digene', and 'Cremaffin' brand names. In addition, it offers various solutions in the areas of thyroid, obesity, diabetes, and benign prostratic hyperplasia. The company also provides various products in the neurology and psychiatric segments as well as in the field of anesthesiology and neonatology. AIL has a network of 18 distribution points, which cater to approximately 11,000 stockists and 70,000 retailers. It was founded in 1944 and is based in Mumbai.
abbott india - 1 Year Stock Price Chart
Price
Rs
1,440.0
No. of shares
m
21.25
Mkt Cap
Rs m
30,600
% ch
%
1.0
Vol
'000
0.0
% ch week
%
-0.7
P/E
X
20.5
% ch 1-mth
%
4.7
P/CF
X
18.6
% ch 12-mth
%
0.2
EPS (TTM)
Rs
70.3
52 week H/L
Rs
1,650.0/1,306.0
(As on May 24, 2013 11:23:00 AM)
» Best Performing pharmaceuticals Stocks
EQUITY SHARE DATA
High
Rs 618 759 1,700 1,683 1,807
Low
Rs 375 362 706 1,178 1,375
Sales per share (Unadj.)
Rs 486.6 556.3 723.6 701.3 777.7 Earnings per share (Unadj.)
Rs 46.0 56.7 44.5 56.7 68.1 Diluted earnings per share Rs 29.6 36.5 28.7 56.7 68.1 Cash flow per share (Unadj.)
Rs 51.1 63.2 52.8 63.7 77.3 Dividends per share (Unadj.)
Rs 14.00 17.00 17.00 17.00 17.00 Adj. dividends per share Rs 9.01 10.94 10.94 17.00 17.00 Dividend yield (eoy)
% 2.8 3.0 1.4 1.2 1.1 Book value per share (Unadj.)
Rs 161.7 198.5 223.2 256.0 304.4 Adj. book value per share Rs 104.1 127.8 143.7 256.0 304.4 Shares outstanding (eoy)
m 13.68 13.68 13.68 21.25 21.25
Bonus/Rights/Conversions
BB - - A -
Price / Sales ratio
x 1.0 1.0 1.7 2.0 2.0
Avg P/E ratio
x 10.8 9.9 27.0 25.3 23.4 P/CF ratio (eoy)
x 9.7 8.9 22.8 22.5 20.6 Price / Book Value ratio
x 3.1 2.8 5.4 5.6 5.2 Dividend payout
% 30.4 30.0 38.2 30.0 25.0
Avg Mkt Cap
Rs m 6,792 7,668 16,457 30,398 33,809
No. of employees
`000 1.2 1.3 1.8 2.4 2.7
Total wages/salary
Rs m 489 624 1,112 1,673 2,061
Avg. sales/employee
Rs Th 5,788.7 5,818.0 5,602.2 6,145.2 6,196.9
Avg. wages/employee
Rs Th 425.2 477.1 629.3 689.9 772.8
Avg. net profit/employee
Rs Th 547.0 592.5 344.7 496.4 542.6
INCOME DATA
Net Sales
Rs m 6,657 7,610 9,899 14,902 16,527 Other income
Rs m 257 293 360 197 223
Total revenues
Rs m 6,914 7,903 10,259 15,099 16,750
Gross profit
Rs m 757 973 694 1,755 2,018 Depreciation
Rs m 70 90 113 150 195
Interest
Rs m 0 2 0 0 0
Profit before tax
Rs m 944 1,174 941 1,802 2,046
Minority Interest
Rs m 0 0 0 0 0
Prior Period Items
Rs m 10 -4 -13 -43 -3
Extraordinary Inc (Exp)
Rs m 0 0 0 0 104
Tax
Rs m 325 395 319 555 700
Profit after tax
Rs m 629 775 609 1,204 1,447 Gross profit margin
% 11.4 12.8 7.0 11.8 12.2 Effective tax rate
% 34.4 33.6 33.9 30.8 34.2
Net profit margin
% 9.4 10.2 6.2 8.1 8.8
BALANCE SHEET DATA
Current assets
Rs m 2,999 3,389 4,029 6,863 7,751
Current liabilities
Rs m 1,248 1,143 1,479 2,385 2,296
Net working cap to sales
% 26.3 29.5 25.8 30.0 33.0 Current ratio
x 2.4 3.0 2.7 2.9 3.4 Inventory Turnover
Days 50 49 47 62 58 Debtors Turnover
Days 18 21 24 32 31 Net fixed assets
Rs m 506 491 506 800 1,092
Share capital
Rs m 137 137 137 212 212
"Free" reserves
Rs m 2,020 2,523 2,861 5,173 6,200
Net worth
Rs m 2,212 2,716 3,054 5,441 6,469
Long term debt
Rs m 6 0 0 0 0
Total assets
Rs m 3,506 3,881 4,534 7,913 9,071 Interest coverage
x NM 588.0 NM NM NM
Debt to equity ratio
x 0.0 0.0 0.0 0.0 0.0 Sales to assets ratio
x 1.9 2.0 2.2 1.9 1.8
Return on assets
% 17.9 20.0 13.4 15.2 16.0 Return on equity
% 28.4 28.5 19.9 22.1 22.4 Return on capital
% 43.0 43.2 30.4 32.3 33.2 Exports to sales
% 0.7 0.6 0.7 0.4 0.7
Imports to sales
% 3.7 5.1 4.4 7.9 10.7
Exports (fob)
Rs m 44 44 74 59 120 Imports (cif)
Rs m 249 389 431 1,176 1,764 Fx inflow
Rs m 73 86 123 113 179 Fx outflow
Rs m 426 547 626 1,517 2,117 Net fx
Rs m -353 -461 -503 -1,404 -1,938
CASH FLOW
From Operations
Rs m 872 372 461 241 1,014 From Investments
Rs m 1,402 -8 -158 51 -585 From Financial Activity
Rs m -811 -234 -272 -420 -420 Net Cashflow
Rs m 1,463 130 31 -129 8
* Results ConsolidatedSource: Company Annual Reports, Regulatory Filings, Equitymaster
» Historical quarterly results for abbott india limited
ITEM Rs m % To R.M.C. % To SALES
Active bulk ingredients
1,367.8
81.8
8.2
Foils
48.3
2.9
0.3
Others
255.2
15.3
1.5
Indian Promoters
:
0.0%
Foreign collaborators
:
75.0%
Indian inst/Mut Fund
:
6.6%
FIIs :
0.0%
ADR/GDR :
0.0%
Free float
:
18.4%
Shareholders
:
20,898
REGD OFF:
3-4, Corporate Park, Sion Trombay Road, Mumbai - 400 071
E-MAIL:
investor.relations@abbott.co.in
WEB:
www.abbott.co.in
TELEPHONE:
(022) 6797 8888
FAX:
(022) 6797 8727
SECTOR:
PHARMACEUTICALS GROUP:
M N C
TR AGENT:
Sharepro Serv., 13 AB, Samhita Warehousing, 2nd Flr, Andheri (E), Mumbai-72
AUDITOR:
Deloitte Haskins & Sells
CHM: Munir Shaikh COMP SEC: Krupa Anandpara YEAR OF INC: 1944 BSE CODE: 500488 FV (Rs): 10 YIELD (%): 1.2
